%0 Journal Article
%T Advances in immune regulation of the G protein-coupled estrogen receptor.
%A Dong H
%A Zeng X
%A Xu J
%A He C
%A Sun Z
%A Liu L
%A Huang Y
%A Sun Z
%A Cao Y
%A Peng Z
%A Qiu YA
%A Yu T
%J Int Immunopharmacol
%V 136
%N 0
%D 2024 Jul 30
%M 38824903
%F 5.714
%R 10.1016/j.intimp.2024.112369
%X Estrogen and related receptors have been shown to have a significant impact on human development, reproduction, metabolism and immune regulation and to play a critical role in tumor development and treatment. Traditionally, the nuclear estrogen receptors (nERs) ERα and ERβ have been thought to be involved in mediating the estrogenic effects. However, our group and others have previously demonstrated that the G protein-coupled estrogen receptor (GPER) is the third independent ER, and estrogen signaling mediated by GPER is known to play an important role in normal physiology and a variety of abnormal diseases. Interestingly, recent studies have progressively revealed GPER involvement in the maintenance of the normal immune system, abnormal immune diseases, and inflammatory lesions, which may be of significant clinical value primarily in the immunotherapy of tumors. In this article, we review current advances in GPER-related immunomodulators and provide a theoretical basis and potential clinical targets to ameliorate immune-related diseases and immunotherapy for tumors.